Expansion of new products, including injection dispensing and audit support systems
First written in FY2020. 3 of 5 entries say "Restated". Latest entry: FY2023.
No other company in this theme has enough history to compare yet.
- FY2023AdvancedAnnual report
「We are currently promoting the handling of new products through business partnerships with external companies, including rentals of new infusion devices, ICT infrastructure services for medical institutions, injection preparation and verification support systems, and breast cancer screening devices.」
A breast cancer screening device was specifically added to the existing new products, clarifying the scope of products whose launch is being promoted. - FY2021RestatedAnnual report
「We are currently promoting the handling of new products through business partnerships with external companies, including rentals of new infusion devices, ICT infrastructure services for medical institutions, and injection preparation and verification support systems. As all of these products are expected to support future growth, we will seek to establish them in the market at an early stage and diversify our business.」
The policy of handling rentals of new infusion devices, ICT infrastructure services for medical institutions, and injection preparation and verification support systems, and diversifying the business through market penetration, continues. - FY2021-Q3RestatedAnnual report
「The rental business for new infusion devices being developed through a business alliance with an external company, ICT services for medical institutions, and the injection dispensing and audit support system are all products expected to see market expansion in the future, and we are working to steadily penetrate their respective markets.」
The policy of diversifying the service business through market penetration of new infusion devices, ICT services for medical institutions, and injection preparation and verification support systems continues. - FY2021-Q1RestatedAnnual report
「Regarding the sale and rental of new infusion devices being developed through a business alliance with an external company, ICT services for medical institutions, and other new products such as injection dispensing and audit support systems, the company aims to achieve steady market penetration in order to diversify the group's services business.」
The policy of diversifying the service business by establishing new products in the market, including new infusion devices, ICT services for medical institutions, and injection preparation and verification support systems, continues. - FY2020First statedAnnual report
「The Group has begun handling new products, including rental of new infusion devices being developed through a business alliance with an external company, ICT services for medical institutions, and injection dispensing and audit support systems. As these products are expected to generate future growth, the Group aims to achieve early market penetration and diversify its services.」
The launch of new products, including injection preparation and verification support systems, and the policy of diversifying services through early market penetration were disclosed for the first time.